Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07178990 · ClinicalTrials.gov registry record · NA
Mobile Platform for Optimizing Wellness and Engagement in Recovery
A NA study of Opioid Use Disorder and Alcohol Use Disorder, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07178990: Recruiting NA study of Opioid Use Disorder and Alcohol Use Disorder, sponsored by University of Michigan.
NCT07178990 is a NA study of Opioid Use Disorder and Alcohol Use Disorder that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 50 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07178990, a NA study of Opioid Use Disorder and Alcohol Use Disorder, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.
Primary Outcome
Recruitment: ≥60% of participants enrolled
Conditions Studied
Interventions
- BEHAVIORAL Digital Contingency Management Intervention Arm
- BEHAVIORAL Digital Wellness Arm
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-08 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT07178990 shows while recruiting
NCT07178990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Digital Contingency Management Intervention Arm is the first listed.
NCT07178990 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07178990 about?
NCT07178990 is a clinical study titled "Mobile Platform for Optimizing Wellness and Engagement in Recovery". This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the fe...
What is the current status of trial NCT07178990?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-08. Estimated completion is 2027-07-31.
What conditions does trial NCT07178990 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Alcohol Use Disorder, Opioid Agonist Treatment.
What interventions are being tested in trial NCT07178990?
The interventions under investigation include: Digital Contingency Management Intervention Arm (BEHAVIORAL), Digital Wellness Arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT07178990?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07178990 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07178990's enrollment target sits among peer trials
50 172nd of 257 higher than 80 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI